Determination of HLA-DR level in cytotoxic T lymphocytes: a new validated tool to predict breast cancer response to treatment
D. P. Saraiva, S. Azeredo-Lopes, A. Antunes, R. Salvador, P. Borralho, B. Assis, I. Pereira, Z. Seabra, I. Negreiros, A. Jacinto, S. Braga, M. G. Cabral
This paper validates HLA-DR expression in cytotoxic T lymphocytes as a predictive biomarker for breast cancer response to neoadjuvant chemotherapy and shows its association with progression-free survival.
bioRxiv · Apr 29, 2021 · PreprintImmunology